Ledger.Open graph →
SEC Form D · Amendment · filed August 29, 2018

Arkis BioSciences Inc

Offering
$3.4M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KNOXVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Chad E. Seaver · Knoxville, TNExec · DirectorStephen A. Arnold · Knoxville, TNExecQuentin A. Aten · Knoxville, TNExecKen A. Woody · Knoxville, TNDirectorJames A. Killeffer, M.D · Knoxville, TNExec · DirectorClif A. Moyers · Knoxville, TNDirectorQuentin A. Aten · Knoxville, TNExecJames A. Killeffer, M.D · Knoxville, TNExec · DirectorKen A. Woody · Knoxville, TNDirectorChad E. Seaver · Knoxville, TNExec · DirectorClif A. Moyers · Knoxville, TNDirectorStephen A. Arnold · Knoxville, TNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗